MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-433

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    Novartis took a punt with a relatively small amount of upfront money, and it didn't work out. Someone will lose their performance bonus.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.